Alterola Biotech : Management Change : vimarsana.com

SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549
____________________


FORM 8-K


CURRENT REPORT


PURSUANT TO SECTION 13 OR 15(d) OF


THE SECURITIES EXCHANGE ...

Related Keywords

Nevada , United States , Washington , Dewi David Hitchcock , David Hitchcock , Daniel Reshef , Securities Exchange , Alterola Biotech Inc , Commission File Number , Squarebirkenhead Merseysideunited , Zip Code , Securities Act , Exchange Act , Securities Exchange Act , Certain Officers , Compensatory Arrangements , Michael Hunter Land , Markets ,